Literature DB >> 19809472

Long-term potentiation: two pathways meet at neurogranin.

Yasunori Hayashi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19809472      PMCID： PMC2760120          DOI： 10.1038/emboj.2009.273

Source DB:  PubMed          Journal:  EMBO J        ISSN： 0261-4189            Impact factor:   11.598


× No keyword cloud information.
  5 in total

1.  Role of the neurogranin concentrated in spines in the induction of long-term potentiation.

Authors:  Anatol M Zhabotinsky; R Nicholas Camp; Irving R Epstein; John E Lisman
Journal:  J Neurosci       Date:  2006-07-12       Impact factor: 6.167

Review 2.  RC3/neurogranin, a postsynaptic calpacitin for setting the response threshold to calcium influxes.

Authors:  D D Gerendasy; J G Sutcliffe
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

3.  Targeted disruption of RC3 reveals a calmodulin-based mechanism for regulating metaplasticity in the hippocampus.

Authors:  Thomas Krucker; George R Siggins; Robert K McNamara; Kristen A Lindsley; Alan Dao; David W Allison; Luis De Lecea; Timothy W Lovenberg; J Gregor Sutcliffe; Dan D Gerendasy
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

4.  Neurogranin enhances synaptic strength through its interaction with calmodulin.

Authors:  Ling Zhong; Tiffani Cherry; Christine E Bies; Matthew A Florence; Nashaat Z Gerges
Journal:  EMBO J       Date:  2009-08-27       Impact factor: 11.598

5.  Common variants conferring risk of schizophrenia.

Authors:  Hreinn Stefansson; Roel A Ophoff; Stacy Steinberg; Ole A Andreassen; Sven Cichon; Dan Rujescu; Thomas Werge; Olli P H Pietiläinen; Ole Mors; Preben B Mortensen; Engilbert Sigurdsson; Omar Gustafsson; Mette Nyegaard; Annamari Tuulio-Henriksson; Andres Ingason; Thomas Hansen; Jaana Suvisaari; Jouko Lonnqvist; Tiina Paunio; Anders D Børglum; Annette Hartmann; Anders Fink-Jensen; Merete Nordentoft; David Hougaard; Bent Norgaard-Pedersen; Yvonne Böttcher; Jes Olesen; René Breuer; Hans-Jürgen Möller; Ina Giegling; Henrik B Rasmussen; Sally Timm; Manuel Mattheisen; István Bitter; János M Réthelyi; Brynja B Magnusdottir; Thordur Sigmundsson; Pall Olason; Gisli Masson; Jeffrey R Gulcher; Magnus Haraldsson; Ragnheidur Fossdal; Thorgeir E Thorgeirsson; Unnur Thorsteinsdottir; Mirella Ruggeri; Sarah Tosato; Barbara Franke; Eric Strengman; Lambertus A Kiemeney; Ingrid Melle; Srdjan Djurovic; Lilia Abramova; Vasily Kaleda; Julio Sanjuan; Rosa de Frutos; Elvira Bramon; Evangelos Vassos; Gillian Fraser; Ulrich Ettinger; Marco Picchioni; Nicholas Walker; Timi Toulopoulou; Anna C Need; Dongliang Ge; Joeng Lim Yoon; Kevin V Shianna; Nelson B Freimer; Rita M Cantor; Robin Murray; Augustine Kong; Vera Golimbet; Angel Carracedo; Celso Arango; Javier Costas; Erik G Jönsson; Lars Terenius; Ingrid Agartz; Hannes Petursson; Markus M Nöthen; Marcella Rietschel; Paul M Matthews; Pierandrea Muglia; Leena Peltonen; David St Clair; David B Goldstein; Kari Stefansson; David A Collier
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962
  5 in total
  9 in total

1.  Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.

Authors:  Erik Portelius; Henrik Zetterberg; Tobias Skillbäck; Ulrika Törnqvist; Ulf Andreasson; John Q Trojanowski; Michael W Weiner; Leslie M Shaw; Niklas Mattsson; Kaj Blennow
Journal:  Brain       Date:  2015-09-15       Impact factor: 13.501

2.  Neurogranin phosphorylation fine-tunes long-term potentiation.

Authors:  Ling Zhong; Kanwardeep S Kaleka; Nashaat Z Gerges
Journal:  Eur J Neurosci       Date:  2010-12-29       Impact factor: 3.386

3.  Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers.

Authors:  Kaitlin B Casaletto; Fanny M Elahi; Brianne M Bettcher; John Neuhaus; Barbara B Bendlin; Sanjay Asthana; Sterling C Johnson; Kristine Yaffe; Cynthia Carlsson; Kaj Blennow; Henrik Zetterberg; Joel H Kramer
Journal:  Neurology       Date:  2017-09-22       Impact factor: 9.910

4.  Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia.

Authors:  Kazutaka Ohi; Ryota Hashimoto; Yuka Yasuda; Kiyotaka Nemoto; Takashi Ohnishi; Motoyuki Fukumoto; Hidenaga Yamamori; Satomi Umeda-Yano; Takeya Okada; Masao Iwase; Hiroaki Kazui; Masatoshi Takeda
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

5.  Effects of the neurogranin variant rs12807809 on thalamocortical morphology in schizophrenia.

Authors:  Jamie Yu Jin Thong; Anqi Qiu; Min Yi Sum; Carissa Nadia Kuswanto; Ta Ahn Tuan; Gary Donohoe; Yih Yian Sitoh; Kang Sim
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

6.  Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer's Disease Continuum.

Authors:  Jun Wang; Xin Zhang; Bihong Zhu; Pan Fu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-20       Impact factor: 2.570

7.  The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease.

Authors:  Hlin Kvartsberg; Tammaryn Lashley; Christina E Murray; Gunnar Brinkmalm; Nicholas C Cullen; Kina Höglund; Henrik Zetterberg; Kaj Blennow; Erik Portelius
Journal:  Acta Neuropathol       Date:  2018-09-22       Impact factor: 17.088

8.  Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer's disease and mild cognitive impairment.

Authors:  Weilin Liu; Huawei Lin; Xiaojun He; Lewen Chen; Yaling Dai; Weiwei Jia; Xiehua Xue; Jing Tao; Lidian Chen
Journal:  Transl Psychiatry       Date:  2020-04-29       Impact factor: 7.989

9.  Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer's Disease.

Authors:  Luisa Agnello; Bruna Lo Sasso; Matteo Vidali; Concetta Scazzone; Tommaso Piccoli; Caterina Maria Gambino; Giulia Bivona; Rosaria Vincenza Giglio; Anna Maria Ciaccio; Vincenzo La Bella; Marcello Ciaccio
Journal:  Diagnostics (Basel)       Date:  2021-12-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.